
CYCN
Healthcare · Biotechnology · $2.2M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 4, 2026 | Time not confirmed | — | -0.41 | — |
| Mar 31, 2026 | Before the open | -0.38 | -0.19 | +50.0% |
| Nov 12, 2025 | Time not confirmed | — | -0.30 | — |
| Aug 5, 2025 | Time not confirmed | — | -0.11 | — |
| May 5, 2025 | After the close | — | -0.56 | — |
| Mar 3, 2025 | After the close | — | 0.21 | — |
| Nov 11, 2024 | After the close | — | -0.29 | — |
| Aug 7, 2024 | Before the open | — | -0.53 | — |
| May 7, 2024 | After the close | — | -0.62 | — |
| Mar 5, 2024 | After the close | — | -0.68 | — |
| Nov 13, 2023 | After the close | — | 3.11 | — |
| Jul 28, 2023 | After the close | -0.28 | -1.83 | -554.4% |
| May 12, 2023 | Before the open | -0.30 | -3.20 | -965.2% |
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and…
| After the close |
| -0.29 |
| -0.17 |
| +41.4% |
| Nov 3, 2022 | After the close | -7.00 | -4.80 | +31.4% |
| Aug 9, 2022 | After the close | -6.80 | -6.20 | +8.8% |
| May 4, 2022 | After the close | -7.20 | -6.00 | +16.7% |
| Feb 24, 2022 | After the close | -0.30 | -0.33 | -10.0% |
| Nov 9, 2021 | After the close | -5.80 | -5.20 | +10.3% |
| Jul 29, 2021 | After the close | — | -0.45 | — |
| Apr 30, 2021 | After the close | — | -0.39 | — |
| Feb 25, 2021 | Before the open | -3.80 | -11.00 | -189.5% |
| Nov 5, 2020 | Before the open | -11.20 | -11.80 | -5.4% |
| Aug 3, 2020 | Before the open | -17.26 | -14.00 | +18.9% |
| May 4, 2020 | After the close | -0.87 | -0.73 | +16.1% |
| Mar 12, 2020 | After the close | -17.84 | -19.00 | -6.5% |
| Nov 12, 2019 | After the close | -25.98 | -20.00 | +23.0% |
| Aug 12, 2019 | Before the open | -16.72 | -23.60 | -41.1% |
| May 13, 2019 | Before the open | — | -0.92 | — |
| Mar 11, 2019 | Time not confirmed | — | -1.99 | — |
| Oct 9, 2018 | Time not confirmed | — | -3.54 | — |